ASF Research Grants
ASF Research Grants from the Angelman Syndrome Foundation fund innovative research to advance treatments, care, and scientific understanding of Angelman syndrome.
Funder: Angelman Syndrome Foundation
Due Dates: September 1, 2027 (Annual Proposal Submission Deadline)
Funding Amounts: Up to $100,000 per year for 1–2 years; indirect costs capped at 10% of total budget.
Summary: Supports innovative research advancing treatments and care for Angelman syndrome, focusing on ASF’s strategic priorities.
Key Information: Open to global academic, clinical, and industry teams; proposals must align with one or more of ASF’s four research pillars.
Description
The Angelman Syndrome Foundation (ASF) Research Grants program funds scientific research to accelerate the development of effective treatments and improve care for individuals with Angelman syndrome. ASF prioritizes studies that align with its strategic research roadmap, emphasizing areas such as UBE3A regulation and function, novel therapeutic strategies, clinical care innovation, and the development of therapeutic endpoints and biomarkers. The program is open to scientists, clinicians, and institutions worldwide, including both academic and industry partners, and encourages collaborative, translational, and impactful projects.
